Excessive fear and anxiety are characteristic of disorders such as post-traumatic stress
disorder (PTSD) and phobias and are believed to reflect abnormalities in neural systems …

Anxiety disorders are among the most common psychological disturbances in the
industrialized world. Current behavioral therapy procedures for these disorders are …

The NMDA receptor partial agonist d-cycloserine (DCS) enhances the extinction of learned
fear in rats and exposure therapy in humans with anxiety disorders. Despite these benefits …

Administration of benzodiazepines or serotonin reuptake inhibitors in combination with
behavior therapy for the treatment of many anxiety disorders has generally lead to only …

In an attempt to improve the efficacy of psychotherapy for anxiety disorders, preclinical
paradigms have recent been translated into novel treatment strategies.[1] Specifically, these …

BACKGROUND: d-cycloserine (DCS) facilitates extinction of learned fear. The aim of this
study was to examine whether DCS 1) affects reacquisition of fear (Experiment 1) and 2) …

The goal of this review is to examine the clinical studies on d-cycloserine, a partial
glutamatergic N-methyl-D-aspartate agonist, as an augmentation strategy for exposure …

Combining an effective psychological treatment with conventional anxiolytic medication is
typically not more effective than unimodal therapy for treating anxiety disorders. However …

Exposure-based therapy, a leading technique in the treatment of a range of anxiety
disorders, is facilitated by D-cycloserine (DCS), a partial N-methyl-D-aspartate receptor …

d-Cycloserine (DCS) may facilitate fear extinction learning, but the behavioral
consequences and mechanisms behind this effect are not well understood at present. In this …